1. Home
  2. LTBR vs MRVI Comparison

LTBR vs MRVI Comparison

Compare LTBR & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightbridge Corporation

LTBR

Lightbridge Corporation

HOLD

Current Price

$14.99

Market Cap

575.6M

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.39

Market Cap

538.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTBR
MRVI
Founded
1992
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
575.6M
538.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LTBR
MRVI
Price
$14.99
$3.39
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$4.57
AVG Volume (30 Days)
1.0M
1.1M
Earning Date
02-25-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$192,435,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.10
$1.67
52 Week High
$31.34
$5.22

Technical Indicators

Market Signals
Indicator
LTBR
MRVI
Relative Strength Index (RSI) 42.86 41.36
Support Level $15.84 $3.30
Resistance Level $18.12 $3.81
Average True Range (ATR) 1.49 0.21
MACD -0.21 -0.06
Stochastic Oscillator 8.24 11.35

Price Performance

Historical Comparison
LTBR
MRVI

About LTBR Lightbridge Corporation

Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: